Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

02.02.2018 | short review | Ausgabe 1/2018 Open Access

memo - Magazine of European Medical Oncology 1/2018

Anti-angiogenic therapies in brain metastases

Zeitschrift:
memo - Magazine of European Medical Oncology > Ausgabe 1/2018
Autoren:
MD, PhD Anna S. Berghoff, MD Matthias Preusser

Summary

Brain metastases are a major challenge in modern oncology, as treatment options upon the diagnosis of symptomatic brain metastases are limited. Neo-angiogenesis was identified as a hallmark of brain metastasis development and inhibition using anti-angiogenic therapy might therefore be an experimental promising preventive as well as therapeutic approach. The current review will summarize the current available data on the efficacy of neo-angiogenic therapies in patients with brain metastases.
Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 1/2018

memo - Magazine of European Medical Oncology 1/2018 Zur Ausgabe